Literature DB >> 6114488

Tetrahydrobiopterin increases in adrenal medulla and cortex: a factor in the regulation of tyrosine hydroxylase.

M M Abou-Donia, O H Viveros.   

Abstract

Tetrahydrobiopterin, the cofactor for tyrosine hydroxylase and other monooxygenases, is present in tissues at apparent concentrations much less than those necessary to saturate the corresponding enzymes. Reserpine treatment or insulin-induced hypoglycemia in rats produces a statistically significant increase in the tetrahydrobiopterin content of both the adrenal medulla and the cortex. Adrenal denervation and hypophysectomy selectively block the increases in cofactor level in medulla and cortex, respectively, while cycloheximide prevents the increase in both tissues. Reserpine did not increase cofactor levels in liver, kidney, or corpus striatum but decreased that of the pineal gland. These results suggest that tetrahydrobiopterin is under neural control in the medulla and hormonal control in the cortex and that increases in cofactor may result from induction of enzyme(s) in the biosynthetic pathway. These results demonstrate regulation of tissue tetrahydrobiopterin and are consistent with the suggestion that cofactor levels participate in the regulation of tyrosine hydroxylase in the adrenal medulla and may have a function, as yet undetermined, in the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114488      PMCID: PMC319425          DOI: 10.1073/pnas.78.5.2703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.

Authors:  R Kettler; G Bartholini; A Pletscher
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

2.  Further studies on the increased synthesis of norepinephrine during nerve stimulation of guinea-pig vas deferens preparation: effect of tyrosine and 6, 7-dimethyltetrahydropterin.

Authors:  G Cloutier; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

3.  Mechanism of secretion from the adrenal medulla. IV. The fate of the storage vesicles following insulin and reserpine administration.

Authors:  O H Viveros; L Arqueros; R J Connett; N Kirshner
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

4.  Increased synthesis of catecholamines in the intact rat following administration of alpha-adrenergic blocking agents.

Authors:  W Dairman; R Gordon; S Spector; A Sjoerdsma; S Udenfriend
Journal:  Mol Pharmacol       Date:  1968-09       Impact factor: 4.436

5.  Increased conversion of tyrosine to catecholamines in the intact rat following elevation of tissue tyrosine hydroxylase levels by administered phenoxybenzamine.

Authors:  W Dairman; S Udenfriend
Journal:  Mol Pharmacol       Date:  1970-07       Impact factor: 4.436

6.  Increase in tyrosine hydroxylase activity after reserpine administration.

Authors:  R A Mueller; H Thoenen; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-09       Impact factor: 4.030

7.  Tyrosine hydroxylase: activation by nerve stimulation.

Authors:  V H Morgenroth; M Boadle-Biber; R H Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

8.  Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens.

Authors:  M C Boadle-Biber; R H Roth
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor.

Authors:  W Lovenberg; E Jequier; A Sjoerdsma
Journal:  Science       Date:  1967-01-13       Impact factor: 47.728

10.  Dihydropteridine reductase: implication on the regulation of catecholamine biosynthesis.

Authors:  J M Musacchio; G L D'Angelo; C A McQueen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

View more
  1 in total

1.  Differences in the metabolism of the aromatic amino acid hydroxylase cofactor, tetrahydrobiopterin, in mutant mice with neurological and immunological defects.

Authors:  D S Duch; S W Bowers; J H Woolf; M T Davisson; L J Maltais; C A Nichol
Journal:  Biochem Genet       Date:  1986-10       Impact factor: 1.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.